Caitong International Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Caitong International Asset Management's VRTX Position: Q2 2026 in Review
Caitong International Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 99% in Q2 2026, selling an estimated $446K and leaving 8 shares worth $3.97K. The position accounts for ﹤0.01% of the portfolio, ranked #1315.
Caitong International Asset Management first reported a position in VRTX in Q4 2024 and has held it in 4 quarters since. The position peaked at $453K in Q1 2026. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Caitong International Asset Management held 8 shares of Vertex Pharmaceuticals worth $3.97K as of Q2 2026.
- Caitong International Asset Management sold 1,006 Vertex Pharmaceuticals shares in Q2 2026, an estimated $446K.
- Vertex Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1315 holding.
- Caitong International Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
- Caitong International Asset Management's Vertex Pharmaceuticals position peaked at $453K in Q1 2026.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.